StrokeAlert- WomenEU Striking Stroke- enhancing and expanding StrokeAlert’s business skills
- Coordinator
- Avertto Medical Ltd, Israel
- Runs
- 1 July 2022 to 30 June 2023
- Status
- Finished
- EU funding
- €75k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101071850
What the project is doing
In the project's own words, from its summary on CORDIS.
Our vision is to preserve Improve the quality of life by reducing silent stroke impact. We will develop, manufacture, and introduce the first easy-to-use device for alerting stroke for high-risk populations. The first market is hospital use during sedation, with the end-stage market being home telemonitoring. The company has a clear patentable product, a large growing market, and an expert and experienced team. StrokeAlert's intellectual property is an alerting system via continuous monitoring of hemodynamic parameters (patent submitted).
StrokeAlert's impact will be reducing morbidity and mortality from stroke. We shall compare patients' neurological outcomes with and without StrokeAlert.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Avertto Medical Ltd | Aderet | Israel | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI